Funds


BioGeneration Ventures I

BioGeneration Ventures I started investing in 2007 and is now fully invested. In BioGeneration Ventures I we have invested in 10 portfolio companies in a broad range of sectors in life sciences. Of the 10 portfolio companies we have successfully exited 5 and 2 are still active.

BioGeneration Ventures II

BioGeneration II invested from 2012 until 2015 in 6 companies.  Based on the exceptional results of the exits Acerta Pharma and Dezima in 2015 and 2016, the fund is now closed for new investments.  4 Companies are still active.  BGV II is supported by the SEED Capital facility of the Dutch government (agentschapnl.nl).

BioGeneration Ventures III

BioGeneration III has started to invest following the first close on 1 July 2016 with the investors of BGVII.  We are still raising further capital for this fund.  BGV III is supported by the SEED Capital facility of the Dutch government (agentschapnl.nl). The fund is investing in opportunities in Europe with a focus on the Netherlands, Belgium and Germany.

Desktop versie